Nonalcoholic fatty liver disease (NAFLD): Is it really a serious condition?

Hepatology

Volumn 56, Issue 4, 2012, Pages 1580-1584

  Wattacheril, Julia ^a   Chalasani, Naga ^b  

^a College of Physicians and Surgeons New York ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME;

BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; FOLLOW UP; GRAFT SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MORTALITY; NEOPLASM; NONALCOHOLIC FATTY LIVER; NOTE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT INDICATION;

EID: 84867152637     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26031     Document Type: Note

References (9)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt E, Cusi K, et al. The diagnosis and management of nonalcoholic fatty liver disease. Developed on behalf of the American Association for the Study of Liver Disease (AASLD), American College of Gastroenterology (ACG), and American Gastroenterology Association (AGA). Hepatology 2012; 55: 2005-2023.
2. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-649.
3. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891.
4. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253.
5. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease; a population-based cohort study. Gastroenterology 2005; 129: 113-121.
6. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263-2271.
7. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008; 48: 608-612.
8. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009; 136: 477-485.
9. Stepanova M, Younossi Z. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US. Clin Gastroenterol Hepatol 2012; 10: 646-650.